On Tuesday, November 5, the Federal Circuit voted 6-4 to deny a request for en banc rehearing in Fresenius vs. Baxter. The court decision in July held that “cancellation of a patent on re-examination can wipe out an infringement judgment.” Finnegan partner James R. Barney told Law360 “The en banc court split dramatically and the dissent uses language flagging this as an important constitutional issue,” he said. “It has all the ingredients to have as a good a chance as any of being taken up by the Supreme Court.”
Barney also said, “What makes this case stand out is the degree to which the district court decision is perceived to be final,” where even a final court decision that the patent is valid and infringed is not final enough. He noted interesting implications in light of new America Invents Act proceedings, adding, “This is a very important case for the bar because of the new post-grant review procedures that are in place and that new emphasis by Congress and the PTO on using those procedures. Patent litigation is high stakes and litigants look for any opportunity to press their advantage.”
Award/Ranking
Finnegan Shortlisted for the 2024 Asian Legal Business Japan Law Awards
April 26, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.